HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Metastatic adenocarcinoma to pelvic lymph node — Clinical Guidelines

Overview

Metastatic adenocarcinoma involving pelvic lymph nodes represents advanced disease often necessitating multidisciplinary surgical approaches, including pelvic lymph node dissection and potentially pelvic exenteration, depending on the extent and prior treatments. 1 2

Diagnosis

Imaging studies (CT, MRI) essential for staging and identifying lymph node involvement.

Histopathological confirmation through biopsy or surgical resection is critical.

Prior history of primary tumor and response to initial treatments (surgery, radiotherapy, chemotherapy) should be evaluated. 2

Management

Surgical Resection: Pelvic lymph node dissection, particularly focusing on obturator lymph nodes, may be indicated for curative intent or palliation. 1

Pelvic Exenteration: Reserved for selected patients with recurrent or advanced disease, performed by experienced surgeons with comprehensive perioperative support. 2

Adjuvant Therapy: Radiotherapy and chemotherapy may precede or follow surgical interventions based on disease stage and prior treatments. Specific drug classes and doses not detailed in provided abstracts.

Special Populations

Prior Treatments: Patients with prior radiotherapy may have reduced operating times and blood loss, though overall complication rates remain significant. 2

Experienced Surgical Teams: Essential for optimal outcomes, particularly in elderly or comorbid patients where perioperative management is complex. 2

Key Recommendations

Conduct multidisciplinary discussions to standardize understanding and techniques for pelvic lymph node dissection, enhancing surgical precision and outcomes. (Evidence: Expert opinion) 1

Pelvic exenteration should be considered for selected patients with advanced or recurrent pelvic adenocarcinoma, performed exclusively by highly experienced surgical teams with access to comprehensive supportive care. (Evidence: Moderate) 2

Prioritize histopathological confirmation and thorough imaging for accurate staging and planning of surgical interventions in patients with metastatic adenocarcinoma involving pelvic lymph nodes. (Evidence: Moderate) 2

References

1 Takemasa I, Hamabe A, Takenaka A, Kobayashi H, Mandai M, Kinugasa Y et al.. Standardization of robot-assisted pelvic lymph node dissection-Development of a common understanding of regional anatomy and surgical technique based on cross-disciplinary discussion among colorectal surgery, urology, and gynecology. Asian journal of endoscopic surgery 2024. link 2 Falk RE, Moffat FL, Makowka L, Konn G, Bulbul MA, Rotstein LE et al.. Pelvic exenteration for advanced primary and recurrent adenocarcinoma. Canadian journal of surgery. Journal canadien de chirurgie 1985. link

Metastatic adenocarcinoma to pelvic lymph node